Profil
Lars Gehlen has worked as an Investment Manager at Abacus alpha GmbH since 2019.
Postes actifs de Lars Gehlen
| Sociétés | Poste | Début |
|---|---|---|
Abacus alpha GmbH
Abacus alpha GmbH Investment ManagersFinance Abacus alpha is an active manager which provides financing for restructuring, insolvencies, successions (buyouts and MBOs), secondary transactions, as well as for early stage and growth capital requirements. It invests in both young companies and established medium-sized enterprises located in Europe, with revenues between EUR 3 million and EUR 50 million. It targets industrial, commercial and service companies which operate in a variety of areas such as industry 4.0, energy & energy efficiency, clean/green technologies, water & waste water, and the like. The company, however, does not focus on companies in the fields of B2C, pharmaceuticals, biotechnology, and chemicals. With a typical investment size between EUR 2 and 30 million and a transaction size between EUR 1 million and 10 million, the firm is open to making both minority and majority investments. | Private Equity Investor | 01/11/2017 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Abacus alpha GmbH
Abacus alpha GmbH Investment ManagersFinance Abacus alpha is an active manager which provides financing for restructuring, insolvencies, successions (buyouts and MBOs), secondary transactions, as well as for early stage and growth capital requirements. It invests in both young companies and established medium-sized enterprises located in Europe, with revenues between EUR 3 million and EUR 50 million. It targets industrial, commercial and service companies which operate in a variety of areas such as industry 4.0, energy & energy efficiency, clean/green technologies, water & waste water, and the like. The company, however, does not focus on companies in the fields of B2C, pharmaceuticals, biotechnology, and chemicals. With a typical investment size between EUR 2 and 30 million and a transaction size between EUR 1 million and 10 million, the firm is open to making both minority and majority investments. | Finance |
















